Insulin Degludec Injection Shortage

• • Insulin Degludec Flextouch Pen subcutaneous solution for injection, Novo Nordisk, 100 units/mL, 3 mL pen injector, 5 count, NDC 73070-0403-15
  • Insulin Degludec Flextouch Pen subcutaneous solution for injection, Novo Nordisk, 200 units/mL, 3 mL pen injector, 5 count, NDC 73070-0503-15

• • Novo Nordisk has insulin degludec and Tresiba vials on shortage due to a short-term manufacturing delay.

• • Tresiba subcutaneous solution for injection, Novo Nordisk, 100 units/mL, 10 mL multiple dose vial, NDC 00169-2662-11
  • Tresiba Flextouch Pen subcutaneous solution for injection, Novo Nordisk, 100 units/mL, 3 mL pen injector, 5 count, NDC 00169-2660-15
  • Tresiba Flextouch Pen subcutaneous solution for injection, Novo Nordisk, 200 units/mL, 3 mL pen injector, 5 count, NDC 00169-2550-13
  • Insulin degludec subcutaneous solution for injection, Novo Nordisk, 100 units/mL, 10 mL multiple dose vial, NDC 73070-0400-11

Estimated Resupply Dates

• • Novo Nordisk has insulin degludec 100 units/mL 3 mL Flextouch pens on back order and the company estimates a release date of early-June 2025. The 200 units/ mL 3 mL Flextouch pens are on allocation.